Back to the Top 100
DeepScribe logo

Rank 98AI & Clinical Intelligence

DeepScribe

Creates an ambient AI clinical documentation platform that extracts structured medical data directly from natural patient conversations.

Visit website
Signal Score
78.9
Total raised
$37M
Stage
Series A
Founded
2019
Headquarters
San Francisco, USA
Region
North America

Their signal

DeepScribe leverages advanced acoustic models to deliver highly reliable clinical documentation, heavily integrated into major outpatient practices and health systems looking to curb clinician burnout.

Signal Score 78.9editorial estimate, see how it is built
Capital (25% weight)74

Total raised, quality of investors and recency of the last round.

Growth (25% weight)80

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)82

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)81

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)79

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in AI & Clinical Intelligence

ShareLink copied

Did we miss something?

Change, add or remove details on this company. Our desk reviews every request.

Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.